Drugs Made In America Acquisition II Corp. (DMIIU) EPS (Basic) (2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly EPS (Basic) of $0.16 for Q4 2025, up 23901.67% quarter-over-quarter from -$0.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) EPS (Basic) (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported EPS (Basic) for 1 consecutive years, with $0.16 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.00 |